Argenica Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	28	98	97	37	37	15
Market Cap Growth	-72.59%	0.85%	162.45%	-1.32%	155.40%	-
Enterprise Value	23	83	88	29	32	13
Last Close Price	0.22	0.76	0.78	0.38	0.43	0.20
PS Ratio	28.07	30.38	37.26	21.08	144.26	49.43
PB Ratio	8.21	13.49	6.94	4.81	4.50	2.14
P/TBV Ratio	8.21	13.49	6.94	4.81	4.50	2.14
EV/Sales Ratio	23.07	25.68	34.02	16.43	123.78	45.30
Net Debt / Equity Ratio	-1.46	-1.46	-1.14	-1.22	-1.07	-1.04
Asset Turnover	0.10	0.23	0.20	0.19	0.03	0.08
Quick Ratio	2.93	2.89	6.71	5.06	12.21	16.97
Current Ratio	2.96	2.90	6.75	5.09	12.29	17.08
Return on Equity (ROE)	-117.81%	-67.68%	-50.70%	-60.29%	-53.99%	-29.99%
Return on Assets (ROA)	-61.45%	-35.03%	-27.35%	-32.79%	-31.35%	-16.82%
Return on Capital Employed (ROCE)	-294.30%	-106.20%	-40.70%	-63.60%	-49.30%	-15.00%
Earnings Yield	-34.68%	-7.34%	-5.66%	-13.05%	-10.95%	-7.03%
Buyback Yield / Dilution	-9.73%	-22.97%	-40.29%	-	-108.80%	-112.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.